SOURCE: Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc.

May 11, 2011 09:00 ET

Therapeutic Solutions International Inc. Signs Distribution Agreement With Alpha Dental Supplies, Ltd. of Canada

SAN DIEGO, CA--(Marketwire - May 11, 2011) - Therapeutic Solutions International, Inc. (OTCQB: TSOI) (PINKSHEETS: TSOI), the only manufacturer of the chairside NTI Tension Suppression System (NTI-tss) that has helped countless patients prevent debilitating migraine and tension headache pain, announced today the signing of a sales and distribution agreement with Alpha Dental Supplies Ltd., a dental supply company headquartered in Toronto, Ontario Canada.

"We are very pleased to sign this sales agreement with Alpha Dental," stated Tim Dixon, President of TSI. "As we continue in our efforts to market this patented technology worldwide, the availability of the NTI Tension Suppression System will allow dentists throughout Canada the ability to provide this unique chairside dental product to their patients."

"The NTI-tss device is one of the most innovative and game-changing products that we have had the pleasure of presenting to Canadian Dentists throughout the Provinces and Territories," said Michael Katz of Alpha Dental Supplies.

Mr. Katz further stated, "This uncomplicated device with its straightforward protocol has allowed thousands of Dentists to provide a solution for patients suffering from TMD, Bruxism, and Migraine Pain problems. We at Alpha Dental look forward to offering the complete NTI-tss product range and expect that our agreement with Therapeutic Solutions International, Inc. will benefit both our companies and the entire Canadian Dental Community over the coming years."

About Alpha Dental Supplies Ltd.

Alpha Dental has been providing new and ground-breaking products to Canadian Dentists for fifty years. Alpha Dental's website is

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc. is a company whose business plan is focused on the development, production and marketing of cost effective technologies and therapeutic modalities for the treatment and prevention of common neurologic, sleep and temporomandibular disorders. TSI has several important websites to disseminate information and market their products. Our clinical research site for the NTI is and our e-commerce portal is located at Our patient education site located at, and our corporate website for TSI is

Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, termination of contracts or agreements, technological obsolescence of our products, technical problems with our research and products, price increases for supplies and components, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at

Contact Information